RxDoctor Payments Data

Victor Lacombe

Facial Plastic Surgery · Santa Rosa, CANPI 1134326556

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 97.5% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $30,584 and has fallen 87.2% since, to $3,923 in 2025. Among facial plastic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$106,325in general payments, 2019–2025

Across 382 payments — averaging $278.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$104K
  • Galderma Laboratories, L.p.$2K
  • Revance Therapeutics, Inc.$783
  • Stryker$76
  • Solta Medical, A Division Of Bausch Health US, LLC$62
$105,144in research payments, 2019–2025

Across 24 payments — averaging $4380.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$105K

What the payments were for

  • Consulting fees$37,30435%
  • Speaking & faculty fees$49,25846%
  • Travel & lodging$12,44212%
  • Food & beverage$7,2877%
  • Education$340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$106,325 in reported general payments places this provider in the 95th percentile of 120 facial plastic surgery providers in California.

See all facial plastic surgery providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron23$265
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha14$143
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$140
Cephalexin35$126
Acyclovir24$100

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Santa Rosa

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →